Laurus Labs' stock, down over 10% from its 52-week high, shows signs of bottoming out. Analysts suggest a buying opportunity ...

Therefore, participants can go long at the current level of ₹465 and buy more shares if the price dips to ₹440. Place ...

Laurus Labs Ltd is quoting at Rs 478.6, up 0.94% on the day as on 12:44 IST on the NSE. The stock is up 20.04% in last one year as compared to a 27.4% spurt in NIFTY and a 55.19% spurt in the Nifty ...

Laurus Labs has seen significant stock volatility since its IPO in 2016, surging during the pandemic but dropping 60% from ...

Ahead of the market opening on Friday, Axis Direct picked five stocks that can generate profits in 5 to 15 days. These are ...

Laurus Labs Ltd share price was up by 0.64% from the previous closing price of ₹478.95. Who are peers of Laurus Labs Ltd? The peers of Laurus Labs Ltd are Sun Pharmaceuticals Industries Ltd ...

Laurus Labs develops active pharmaceutical ingredients, the chemicals that give drugs their medicinal properties. It focuses on hepatitis C, HIV and cancer drugs. The company was founded in 2005 ...

Rajesh Palviya has recommended to buy, hold, and accumulate Laurus Labs Ltd, Polycab India Ltd, and Siemens Ltd.

Laurus Labs Ltd is quoting at Rs 461.2, up 1.61% on the day as on 12:49 IST on the NSE. The stock is up 15.21% in last one year as compared to a 26.28% jump in NIFTY and a 54.8% jump in the Nifty ...

The PE firm's other investments in the Indian healthcare sector include Meril Life Sciences, MedPlus, Laurus Labs, and Metropolis Healthcare. 2DG has been given emergency approval by the Drugs ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...